Kyunghee Lim

Kyunghee Lim

Auto-generated profile, based on publicly available information

Kyunghee Lim

Department of Cardiology, Dong-A University Hospital, Busan, Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Korean Circulation Journal
Verified
Journal Article
Open access
KLKyunghee Lim
Kyunghee Lim
SCSung-A Chang
Sung-A Chang
SOSoo-young Oh
Soo-young Oh
JLJong-Hwan Lee
Jong-Hwan Lee
JSJinyoung Song
Jinyoung Song
DKDuk-Kyung Kim
Duk-Kyung Kim
Lim K, et al. Korean Circ J. 2018 Aug;49:e50. https://doi.org/10.4070/kcj.2018.0350

HKHye Re Kim
Hye Re Kim
KLKyunghee Lim
Kyunghee Lim
SPSeung-Jung Park
Seung-Jung Park
JPJong-Sung Park
Jong-Sung Park
JKJu Youn Kim
Ju Youn Kim
JKJune Soo Kim
June Soo Kim
(1) Background: Limited data exist on the safety and efficacy of epicardial left ventricular (LV) lead placement using video-assisted thoracoscopic surgery (VATS) for cardiac resynchronization therapy (CRT). (2) Methods: Acute and post-discharge outcomes of CRT were compared between patients with epicardial LV leads (Epicardial-LV group, n = 13) and those with endocardial LV leads (Endocardial-LV group, n = 243). (3) Results: Epicardial LV leads were implanted via VATS alone (n = 8) or along with mini-thoracotomy (n = 5), for failed endocardial implantation (n = 11) or recurrent lead dislodgement (n = 2). All epicardial procedures under general anesthesia with one-lung ventilation were successfully completed in 1.0 ± 0.4 h without phrenic nerve stimulation. LV pacing thresholds in the epicardial-LV (1.5 ± 1.0 V) and endocardial-LV (1.3 ± 0.8 V) were comparable (p = 0.651). All patients were discharged alive post-VATS 8.8 ± 3.9 days. During the follow-up (34.3 ± 28.6 months), all patients with epicardial LV leads stayed alive except for one cardiac death post-CRT 14 months and one heart transplantation post-CRT 30 months. All epicardial LV leads maintained stable performance without dislodgement/significant changes in pacing threshold/impedance. LV lead dislodgement occurred only in endocardial-LV (7/243, 2.9%). Efficacy in both groups was comparable in terms of QRS narrowing, increase in LV ejection fraction, and survival free of cardiac death, or heart-failure-related hospitalization. (4) Conclusions: Epicardial LV lead placement using VATS can be a safe and effective alternative to endocardial implantation, with comparable acute and post-discharge outcomes achieved by both approaches.

8 June 2023 in European Heart Journal - Cardiovascular Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
MKMoo Hyun Kim
Moo Hyun Kim
SYSong Lin Yuan
Song Lin Yuan
KLKwang Min Lee
Kwang Min Lee
XJXuan Jin
Xuan Jin
ZSZhao Yan Song
Zhao Yan Song
SCSun Young Choi
Sun Young Choi
Atrial fibrillation (AF) is linked to an increased risk of dementia, even in stroke-free patients. The impact of statin therapy on dementia risk is unclear in AF patients receiving oral anticoagulant (OAC) (vitamin K antagonist and direct-acting oral anticoagulant). We sought to investigate the impact of statin therapy on dementia risk in AF patients receiving OAC. Using the Korean National Health Insurance Service database, 91 018 non-valvular AF (NVAF) patients from January 2013 to December 2017 were included in the analysis. Of the total, 17 700 patients (19.4%) were in the statin therapy group, and 73 318 patients (80.6%) were in the non-statin therapy group. The primary endpoint was the occurrence of dementia. The median duration of follow-up was 2.1 years. Statin therapy was associated with a significantly lower dementia risk than non-statin therapy for CHA2DS2-VASc scores ≥ 2 (HR = 0.77, 95% CI 0.64–0.90, p = 0.026) in NVAF patients receiving OAC. The statin therapy group had a significantly lower dementia risk in a dose-dependent relationship compared with the non-statin therapy group (p for trend < 0.001). In NVAF patients who received OAC, statin therapy lowered the dementia risk compared with no statin therapy. Furthermore, statin therapy is associated with a dose-dependent reduction in dementia risk.

20 July 2021 in Heart
Verified
Journal Article
Closed access
PDF file
KLKyunghee Lim
Kyunghee Lim
JYJeong Hoon Yang
Jeong Hoon Yang
WMWilliam R Miranda
William R Miranda
SCSung-A Chang
Sung-A Chang
DJDong Seop Jeong
Dong Seop Jeong
JOJae K Oh
Jae K Oh
Objectives: We investigated haemodynamics and clinical outcomes according to type of pulmonary hypertension (PH) in patients with constrictive pericarditis (CP).Background: As the prevalence of CP with concomitant myocardial disease (mixed CP) grows, PH is more commonly seen in patients with CP. However, haemodynamic and outcome data according to the presence or absence of PH are limited.Methods: 150 patients with surgically confirmed CP who underwent echocardiography and cardiac catheterisation within 7 days at two tertiary centres were divided into three groups: no-PH, isolated postcapillary PH (Ipc-PH) and combined postcapillary and precapillary PH (Cpc-PH). Primary outcome was all-cause mortality during follow-up.Result: In this retrospective cohort study, 110 (73.3%) had PH (mean pulmonary artery pressure ≥25 mm Hg). Cpc-PH, using defined cut-offs for pulmonary vascular resistance (>3 Wood units) or diastolic pulmonary gradient (≥7 mm Hg), was seen in 18 patients (12%). The Cpc-PH group had a higher prevalence of comorbidities (diabetes and atrial fibrillation) and concomitant myocardial disease as an aetiology of CP than other groups. Pulmonary vascular resistance had a significant direct correlation with medial E/e′ by Doppler echocardiography (r=0.404, p<0.001). Survival rate was significantly lower in the Cpc-PH than the no-PH (p=0.002) and Ipc-PH (p=0.024) groups. On multivariable analysis, age, New York Heart Association functional class IV, medial e′ velocity, Cpc-PH and Ipc-PH were independently associated with long-term mortality.Conclusion: Combined postcapillary and precapillary PH develops in a subset of patients with CP and is associated with long-term mortality after pericardiectomy.

6 October 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
KLKyung Hee Lim
Kyung Hee Lim
JPJong-Sung Park
Jong-Sung Park
Lim KH, et al. J Korean Med Sci. 2022 Oct;37(42):e306. https://doi.org/10.3346/jkms.2022.37.e306

Verified
Journal Article
Open access
PDF file
XJXuan Jin
Xuan Jin
Eun-Ju KangEun-Ju Kang
Eun-Ju Kang
Cai De JinCai De Jin
Cai De Jin
KLKwang Min Lee
Kwang Min Lee
KLKyung-Hee Lim
Kyung-Hee Lim
MKMoo Hyun Kim
Moo Hyun Kim
Background: Vasospastic angina (VSA) is characterized by chest pain at rest with transient ischemic electrocardiographic changes in the ST segment, and a prompt response to nitrates. Vasospastic angina is among the most frequent of the coronary artery diseases in Asia, and coronary computed tomography angiography (CCTA) may become available as a non-invasive diagnosis method. Methods: We prospectively enrolled 100 patients with suspected vasospastic angina at two centers from 2018 to 2020. All patients underwent baseline CCTA without a vasodilator in the early morning followed by catheterized coronary angiography and spasm testing. CCTA with intravenous infusion of nitrate (IV) was repeated within 2 weeks of baseline CCTA. Vasospastic angina as detected by CCTA was defined as significant stenosis (≥50%) with negative remodeling without definite plaques or diffuse small diameter (<2 mm) of a major coronary artery with a beaded appearance on baseline CT that completely dilated on IV nitrate CT. We analyzed diagnostic performance of dual-acquisition CCTA for the detection of vasospastic angina. Results: The patients were categorized into three groups according to their provocation test result (negative, n = 36; probable positive, n = 18; positive, n = 31). The diagnostic accuracy in terms of CCTA per patient had a sensitivity of 55% (95% CI, 40–69), specificity of 89% (95% CI, 74–97), positive predictive value (PPV) of 87% (95% CI, 72–95), and negative predictive value (NPV) of 59% (95% CI, 51–67). Conclusions: Dual-acquisition CCTA can support the non-invasive detection of vasospastic angina with relatively good specificity and PPV. CCTA was helpful for non-invasive screening of variant angina.